Key facts
- It has raised $345.6M; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include Khosla Ventures, MedTech Innovator, The Invus Group, Samsara BioCapital, HBM Partners — 27 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Genalyte
- ·The full record, as it builds
Funding rounds
No funding rounds for Genalyte are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Genalyte
Developer of a diagnostic testing system designed to deliver rapidly deployable mobile laboratories with real-time diagnostics anywhere in the delivery system. The company performs the majority of tests, in any healthcare setting with a rapidly deployable mobile laboratory, in under thirty minutes and the central lab handles tests that cannot be performed onsite, enabling physicians to improve the quality of care for patients and reduce resource utilization across the healthcare system.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2007
- Employees
- 86
- Website
- genalyte.com/
- Ownership
- Privately Held (backing)
Genalyte doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Genalyte shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Genalyte in its N-PORT filings yet. We sweep new filings monthly.